Serum Institute qHPV vaccine against cervical cancer to be launched by year-end, says Adar Poonawalla - Video
|
Overview
India's first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched in a few months and made available to the people in an range of Rs 200-400, Serum Institute of India CEO Adar Poonawalla said on Thursday.
Speaking at an event held to announce the scientific completion of the vaccine, Union Minister of Science and Technology Jitendra Singh said the vaccine will be affordable and the government will ensure that it is accessible to the common man.
For more details, check out the link given below:
Speakers
Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
